SMITH & NEPHEW PLC
22 May 2024
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020
On 20 and 21 May 2024, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.
All figures in these columns are stated to 6 decimal places where applicable.
i. FINAL VESTING OF 2021 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
The awards were granted under the Global Share Plan 2020 on 21 May 2021. One third of the Shares vested on 21 May 2022, a further third vested on 21 May 2023 and the final third vested on 21 May 2024. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
The following relates to individuals included in the below notification:
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Final vesting on 21 May 2024 of Conditional Share awards granted on 21 May 2021 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability |
Date of Transaction | 2024 - 05 - 21 |
Place of Transaction | London Stock Exchange (XLON) |
Name (Position) |
Status | Price (£) | Volume | Aggregated information |
Craig Gaffin President, Global Orthopaedics | PDMR | 10.1175
| 1,522 (of which 372 were sold and 1,150 were retained.) | N/A Single Transaction |
Scott Schaffner (President Sports Medicine) | PDMR | 10.1175
| 1,141 (of which 279 were sold and 862 retained.) | N/A Single Transaction |
ii. PARTIAL VESTING OF 2022 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
The awards were granted under the Global Share Plan 2020 on 12 August 2022. One quarter of the Shares vested on 20 May 2023, a further quarter vested on 20 May 2024 and the final half will vest on 20 May 2025. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
The following relates to individuals included in the below notification:
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Partial vesting on 20 May 2024 of Conditional Share awards granted on 12 August 2022 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability |
Date of Transaction | 2024 - 05 - 20 |
Place of Transaction | London Stock Exchange (XLON) |
Name (Position) |
Status | Price (£) | Volume | Aggregated information |
Elga Lohler (Chief HR Officer) | PDMR | 10.290135 | 10,088 (of which 4,010 were sold and 6,078 were retained.) | N/A Single Transaction |
iii. PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
The awards were granted under the Global Share Plan 2020 on 19 May 2023. One quarter of the Shares vested on 20 May 2024, a further quarter will vest on 19 May 2025 and the final half will vest on 19 May 2026. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
The following relates to individuals included in the below notification:
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument
| Smith & Nephew plc ordinary shares of USD 0.20 each
|
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Partial vesting on 20 May 2024 of Conditional Share awards granted on 19 May 2023 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability |
Date of Transaction | 2024 - 05 - 20 |
Place of Transaction | London Stock Exchange (XLON) |
Name (Position) |
Status | Price (£) | Volume | Aggregated information |
Craig Gaffin President, Global Orthopaedics | PDMR | 10.290135 | 1,551 (of which 379 were sold and 1,172 were retained.) | N/A Single Transaction |
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477100
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.